Watchdog condemns drug trial firm
The Government's drug watchdog today criticised the firm behind a disastrous drug trial which left six men seriously ill.
Research firm Parexel failed to follow some correct procedures and made errors over contracts and patient records, the Medicines and Healthcare products Regulatory Agency (MHRA) said in its final report into the incident earlier this year.
But, it said, the adverse reaction seen in the men was most likely down to an "unpredicted biological action of the drug in humans".
That conclusion is the same one the MHRA came to in its previous interim report.
In the report, the MHRA outlines an inspection of Parexel carried out after it suspended the trial when the men fell ill in March.
All six previously healthy men suffered multiple organ failure after being given TGN1412, which is designed to treat rheumatoid arthritis, leukaemia and multiple sclerosis.
They were placed in intensive care and one sufferer was described as looking like "The Elephant Man".
The report said Parexel, which is based at Northwick Park Hospital in north west London, had "failed to complete the full medical background of a trial subject in writing".
One investigator had not updated records after a verbal consultation with one of the volunteers, it said.
The placebo volunteers were also allowed to leave the premises "before appropriate checks were undertaken to confirm that they were the two subjects that had received the placebo", it added.
This should have been done, despite the fact that events suggested they were the ones taking the placebo, the MHRA said.
Furthermore, the bank screening physician - the doctor who screens the volunteers before they enter a trial - did not have a contract.
The report said: "Having interviewed the bank screening physician as part of their inspection, MHRA inspectors were not satisfied that the individual had adequate training and experience for their role."
There was also no "formal system" in place for 24-hour medical cover and no contract in place between manufacturer TeGenero and Parexel, although one was subsequently issued, it said.
Life & Style blogs
Snapchat removed the Best Friends list feature and 'stalkers' are upset
Baldness could soon be treated using stem cells, scientists hope
A bottle of wine a day is not bad for you and abstaining is worse than drinking, scientist claims
Eight-year-old girl Camilla Lisant suggests possible cure for cancer to her scientist father
Lack of medically trained staff leaves NHS 111 phone service struggling to cope, insider claims
- 2 The awkward moment Sarah Palin raised $25,000 for Hillary Clinton's election campaign
- 3 Ball pool for adults opens in London
- 4 Amal Clooney gives excellent response to fashion question at European Court of Human Rights
- 5 Baldness could soon be treated using stem cells, scientists hope
£40000 per annum: Ashdown Group: A reputable organisation within the leisure i...
£90 - £140 per day: Tradewind Recruitment: I am currently working in partnersh...
£96000 - £200000 per annum: Recruitment Genius: Looking for a better earning p...
£32000 - £36000 per annum: Recruitment Genius: A rapidly expanding company in ...